Wellington Management Group LLP Pmv Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.01 - $8.93 $138,590 - $205,925	-23,060 Reduced 4.07%	542,883 $3.33 Million
Q2 2023 Aug 14, 2023	SELL	$3.94 - $6.27 $1.2 Million - $1.91 Million	-304,111 Reduced 34.95%	565,943 $3.54 Million
Q1 2023 May 12, 2023	BUY	$4.77 - $9.16 $216,958 - $416,633	45,484 Added 5.52%	870,054 $4.15 Million
Q4 2022 Feb 13, 2023	SELL	$8.17 - $12.95 $2.19 Million - $3.48 Million	-268,546 Reduced 24.57%	824,570 $7.17 Million
Q3 2022 Nov 14, 2022	SELL	$11.4 - $17.18 $404,141 - $609,048	-35,451 Reduced 3.14%	1,093,116 $13 Million
Q2 2022 Aug 15, 2022	BUY	$9.23 - $22.43 $9.82 Million - $23.9 Million	1,064,111 Added 1650.91%	1,128,567 $16.1 Million
Q1 2022 May 16, 2022	BUY	$14.86 - $23.55 $492,148 - $779,952	33,119 Added 105.69%	64,456 $1.34 Million
Q4 2021 Feb 11, 2022	BUY	$19.99 - $30.24 $626,426 - $947,630	31,337 New	31,337 $724,000
Q3 2021 Nov 15, 2021	SELL	$26.84 - $36.58 $26 Million - $35.5 Million	-970,364 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$28.01 - $36.01 $1.05 Million - $1.35 Million	-37,359 Reduced 3.71%	970,364 $33.1 Million
Q1 2021 May 17, 2021	SELL	$30.66 - $49.5 $9.12 Million - $14.7 Million	-297,456 Reduced 22.79%	1,007,723 $33.1 Million
Q4 2020 Feb 12, 2021	SELL	$31.86 - $61.51 $10.9 Million - $21 Million	-340,643 Reduced 20.7%	1,305,179 $79.2 Million
Q3 2020 Nov 16, 2020	BUY	$35.5 - $38.0 $58.4 Million - $62.5 Million	1,645,822 New	1,645,822 $57.1 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.